Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
   
Ask the Experts About

Choosing Your MedsChoosing Your Meds
         
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


My second review

Jun 25, 2017

Hello doctor, thank you very much for helping in this forum. I am positive since October 2016, I started my therapy with KIVEXA and EVOTAZ at the end of October with cv 305000 copies and cd4 335, in my first review at two months my cv was 63, my cd4 of 498 (8.7% ) And cd8 4067 (71.1%). After 5 months in my second review, my cv is 21, my cd4 are 455 (11.5%), cd8 2677 (67.7%). My question is why I dropped so fast my cv in two months to only 63, and after 5 months, is still 21. Could I be starting to fail the treatment or what do you think? My doctor says to continue with the same treatment, thank you very much.

Response from Dr. Holodniy

I am not concerned and agree with your doctor. You have had a great response to HIV treatment. Sometimes it can take 6 months or longer for the HIV viral load to become undetectable. So I agree you should continue with the same treatment.



Previous
RPR titer stopped decreasing?
Next
Living with out treating HIV

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement